Evidence map›Paper›PMID 30920923›Full record

ArticleCirculation research2019

Precision Medicine.

Joseph Loscalzo

Abstract read
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Physiological genomics · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Network medicine in Cardiovascular Research.Cardiovascular research · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Network Medicine in Pathobiology.The American journal of pathology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joseph LoscalzoFrom the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Funding

Boston Biomedical Innovation CenterU54HL119145 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLAN, DAVID E., LOSCALZO, JOSEPH · 2013 to 2021
$18.8M
TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI GOLAN, DAVID E. · 2014 to 2018
$10.8M
Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
GPx-3 and Peroxide Flux in the Endothelial CellR37HL061795 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2007 to 2016
$4.3M
PLATELET DERIVED REACTIVE OXYGEN SPECIES AND PLAQUER01HL061795 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 1998 to 2006
$1.6M
NHGRI NIH HHS U01 HG007690NHLBI NIH HHS R01 HL061795NHLBI NIH HHS R37 HL061795NHLBI NIH HHS U54 HL119145NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Precision MedicineAntihypertensive AgentsBlood PressureClinical Decision-MakingEssential HypertensionGenetic Predisposition to DiseaseHumansMolecular Diagnostic TechniquesPatient SelectionPhenotypePredictive Value of TestsRisk FactorsTreatment OutcomeAntihypertensive Agentsatrial fibrillationblood pressuregenomicshypertension

Identifiers

PMID30920923
PMCPMC6501802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.